title: Persistent suppression of granulo-erythropoietic precursor cells in alpha interferon treated CML patients undergoing autologous stem cell transplantation: in vitro and clinical results.
authors.affiliation: Institute of Hematology, University La Sapienza, Rome, Italy.
authors.forename: P
authors.initials: P
authors.lastname: De Fabritiis
authors.forename: A
authors.initials: A
authors.lastname: Sandrelli
authors.forename: G
authors.initials: G
authors.lastname: Meloni
authors.forename: L
authors.initials: L
authors.lastname: De Felice
authors.forename: G
authors.initials: G
authors.lastname: Di Matteo
authors.forename: G
authors.initials: G
authors.lastname: Alimena
authors.forename: E
authors.initials: E
authors.lastname: Montefusco
authors.forename: D
authors.initials: D
authors.lastname: Defazio
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
mesh_terms: D000328:Adult; D002871:Chromosome Banding; D003114:Colony-Forming Units Assay; D015672:Erythroid Precursor Cells / Q000187:drug effects* / Q000637:transplantation; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008677:Metaphase / Q000187:drug effects; D008875:Middle Aged; D011994:Recombinant Proteins; D013997:Time Factors; D014182:Transplantation, Autologous
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins